BioVie (NASDAQ:BIVIW) Shares Break Below 200 Day Moving Average – Here’s What Happened

BioVie Inc. (NASDAQ:BIVIW) passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.32 and traded as low as $0.2908. BioVie shares last traded at $0.2908, with a volume of 903 shares.

BioVie Price Performance

The business’s fifty day simple moving average is $0.31 and its two-hundred day simple moving average is $0.32.

BioVie Inc is a clinical-stage biopharmaceutical company developing therapies for neurological and liver-related disorders. Its research focuses on conditions associated with chronic inflammation, insulin resistance, neurodegeneration and impaired liver function, areas in which the company seeks to address significant unmet medical needs.

The company’s lead investigational product is bezisterim, also known as NE3107, an orally administered compound being studied for neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease.